|ACPM Listening Sessions on the CDC's 6|18 Initiative|
ACPM and the Centers for Disease Control and Prevention (CDC) hosted three in-person listening sessions to explore the role of providers in implementing the CDC's 6|18 Initiative, which targets six common and costly health conditions:
This was an opportunity for physicians and health professionals from New York City, Houston and Atlanta to share their expertise, engage with fellow providers, and be a voice for prevention in their community.
Information about the listening sessions—including agenda, presentations, photos and more—has been made available on separate pages for each event.
This listening sessions were intended for all physicians involved or interested in preventing or addressing these common and costly health conditions. Participants discussed and identified:
Advance Reading Materials
The following reading materials were made available prior to the listening session to allow participants to gain additional background information on the 6|18 initiative and contribute to a substantive discussion.
Health Systems Transformation
This listening session is made possible through a grant from the CDC as part of a five year cooperative agreement on health systems transformation.
By the end of the session participants were be able to:
CDC is partnering with health care purchasers, payers, and providers to improve health and control health care costs. CDC provides these partners with rigorous evidence about high-burden health conditions and associated interventions to inform their decisions to have the greatest health and cost impact. The 6|18 Initiative offers proven interventions that prevent chronic and infectious diseases by increasing their coverage, access, utilization and quality. Additionally, it aligns evidence-based preventive practices with emerging value-based payment and delivery models. By 6|18, we mean that we are targeting six common and costly health conditions—tobacco use, high blood pressure, healthcare-associated infections, asthma, unintended pregnancies, and diabetes—and 18 proven specific interventions that formed the starting point of discussions with purchasers, payers, and providers.